Postherpetic Neuralgia Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Postherpetic Neuralgia Clinical Trials Market Report Overview
There were a total of 531 postherpetic neuralgia clinical trials conducted as of February 2023. The postherpetic neuralgia clinical trial market research report provides a comprehensive overview of the market across regions and countries (G7 & E7). It also provides insights into the various phases, trial status, and end points status. The report includes information about the sponsor types and the prominent sponsors associated with the trials as well.
Postherpetic Neuralgia Clinical Trials Market Segmentation by Regions
A few of the key regions where postherpetic neuralgia clinical trials are conducted are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America. As of February 2023, Asia-Pacific accounted for the highest share of the regional landscape. Sponsors conducted more than 40% of the trials in this region.
Postherpetic Neuralgia Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Postherpetic Neuralgia Clinical Trials Market
Key Regions | · North America
· Europe · Asia-Pacific · Middle East & Africa · South & Central America |
Key Countries | · China
· The US · Japan · Germany · The UK |
Leading Sponsors | · Viatris Inc
· Pfizer Inc · Daiichi Sankyo Co Ltd · Astellas Pharma Inc · GSK plc |
Key Sponsor Types | · Company
· Institution · Government |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Postherpetic Neuralgia Clinical Trials Market Segmentation by and Countries
- Country Insights
China had the highest number of postherpetic neuralgia clinical trials, as of February 2023. Meanwhile, the US had the highest average patient enrollment as of February 2023.
- G7 Countries
Among the G7 (US, UK, Germany, France, Italy, Canada, and Japan) countries, Japan had the highest proportion of postherpetic neuralgia to central nervous system clinical trials as of February 2023.
- E7 countries
Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, China had the highest proportion of postherpetic neuralgia to central nervous system clinical trials as of February 2023.
Postherpetic Neuralgia Clinical Trials Analysis by Countries, 2023 (%)
Buy the Full Report for More Country Insights into the Postherpetic Neuralgia Clinical Trials Market
Postherpetic Neuralgia Clinical Trials Market - Competitive Landscape
A few of the leading sponsors associated with the market are:
- Viatris Inc.
- Pfizer Inc.
- Daiichi Sankyo Co Ltd
- Astellas Pharma Inc.
- GSK plc
Viatris Inc. conducted the highest number of postherpetic neuralgia clinical trials in 2023.
Postherpetic Neuralgia Clinical Trials Market Analysis by Sponsors, 2023 (%)
Buy the Full Report for More Sponsor Insights into the Postherpetic Neuralgia Clinical Trials Market
Postherpetic Neuralgia Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the market are companies, institutions, and the government. Out of them, the company segment dominated the market in February 2023.
Postherpetic Neuralgia Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
Buy the Full Report for More Sponsor Type Insights into the Postherpetic Neuralgia Clinical Trials Market
Segments Covered in the Report
Postherpetic Neuralgia Clinical Trials Regional Outlook (2023)
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South and Central America
Postherpetic Neuralgia Clinical Trials Country Outlook (2023)
- China
- The US
- Japan
- Germany
- The UK
Postherpetic Neuralgia Clinical Trials Regional Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status.
- The report reviews the top companies involved and enlists all trials pertaining to the company.
- The report provides all the unaccomplished trials with reasons for unaccomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
Pfizer Inc
Daiichi Sankyo Co Ltd
Astellas Pharma Inc
GSK plc
AbbVie Inc
Sorrento Therapeutics Inc
Merck & Co Inc
Teva Pharmaceutical Industries Ltd
Grunenthal GmbH
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of postherpetic neuralgia clinical trials in February 2023?
Asia-Pacific accounted for the highest number of postherpetic neuralgia clinical trials as of February 2023.
-
Which country conducted the highest number of postherpetic neuralgia clinical trials in February 2023?
China conducted the highest number of postherpetic neuralgia clinical trials as of February 2023.
-
Which sponsor type was the most prominent in the postherpetic neuralgia clinical trials in February 2023?
As of February 2023, the company sponsor type conducted most of the postherpetic neuralgia clinical trials.
-
Which are the leading sponsors of postherpetic neuralgia clinical trials?
A few of the leading sponsors of postherpetic neuralgia clinical trials are Viatris Inc., Pfizer Inc., Daiichi Sankyo Co Ltd, Astellas Pharma Inc., and GSK plc, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.